FR EN

Back


27/11/2014
Idinvest makes 7.6x return with biotech exit
Paris-based private equity firm Idinvest is set to make a 7.6 return multiple on its $840 million sale of NASDAQ-listed biotechnology company Prosensa, according to a statement.




X

X

X